Skip to content

How It Works Pricing Blog Events Partners

Sign In Get Started →

How It Works Pricing Blog Events Partners

Sign In Get Started →

Loading people...

The OS for early-stage founders from day zero to raise.

Product

How It Works Pricing Partners

Resources

Blog Events Contact

Company

About Privacy Terms

© 2026 Startup Intros, Inc.San Francisco, CA · Made for Founders

Home
/People
/Eric Krauland

§ Investor Profile

Eric Krauland

Updated:Apr 2, 2026

About News Experience Investments FAQs

Quick Facts

Role: President and Chief Scientific Officer
Company: Adimab
Status: Active
Type: Investor

Subscribe, Save or Share

Join 25K+ founders & VCs who start their week informed.

Recent News & Mentions

Apr 1, 2012FundingAdimab - Series F Jan 1, 2010FundingAdimab - Series D Nov 1, 2008FundingAdimab - Series C Mar 1, 2008FundingAdimab - Series B Jul 1, 2007FundingAdimab - Series A

Experience

President and Chief Scientific OfficerCurrent

Present - Present

Frequently Asked Questions

Who is Eric Krauland?

Eric Krauland is President and Chief Scientific Officer at Adimab.